Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Assets    
Financing receivables $ 1,012,522 $ 1,042,237
Investments 124,859 58,058
Real estate 288,602 172,257
Equity method investments 449,165 363,297
Cash and cash equivalents 16,331 29,428
Other assets 151,715 80,610
Total Assets 2,043,194 1,745,887
Liabilities:    
Accounts payable, accrued expenses and other 35,475 25,219
Deferred funding obligations 174,601 170,892
Credit facilities 406,487 283,346
Nonrecourse debt (secured by assets of $954 million and $864 million, respectively) 789,827 692,091
Total Liabilities 1,406,390 1,171,548
Stockholders' Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 50,194,089 and 46,493,155 shares issued and outstanding, respectively 502 465
Additional paid in capital 734,625 663,744
Accumulated deficit (102,090) (92,213)
Accumulated other comprehensive income (loss) 64 (1,388)
Non-controlling interest 3,703 3,731
Total Stockholders' Equity 636,804 574,339
Total Liabilities and Stockholders' Equity $ 2,043,194 $ 1,745,887